Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer

समान संसाधन

• Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
  द्वारा: Priceman, Saul J., और अन्य
  प्रकाशित: (2017)
• Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
  द्वारा: Priceman, Saul, और अन्य
  प्रकाशित: (2015)
• Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
  द्वारा: Park, Anthony K, और अन्य
  प्रकाशित: (2015)
• Smart CARs Engineered for Cancer Immunotherapy
  द्वारा: Priceman, Saul J., और अन्य
  प्रकाशित: (2015)
• PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
  द्वारा: Mark N. Stein, और अन्य
  प्रकाशित: (2024-12-01)